Jeremy Curnock Cook Net Worth

The estimated Net Worth of Jeremy Curnock Cook is at least $228 Thousand dollars as of 13 December 2023. Jeremy Cook owns over 2,518 units of AVITA Medical Inc stock worth over $197,104 and over the last 8 years Jeremy sold RCEL stock worth over $30,896.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Jeremy Cook RCEL stock SEC Form 4 insiders trading

Jeremy has made over 1 trades of the AVITA Medical Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Jeremy sold 2,518 units of RCEL stock worth $30,896 on 13 December 2023.

The largest trade Jeremy's ever made was selling 2,518 units of AVITA Medical Inc stock on 13 December 2023 worth over $30,896. On average, Jeremy trades about 315 units every 0 days since 2016. As of 13 December 2023 Jeremy still owns at least 20,596 units of AVITA Medical Inc stock.

You can see the complete history of Jeremy Cook stock trades at the bottom of the page.

What's Jeremy Cook's mailing address?

Jeremy's mailing address filed with the SEC is C/O AVITA MEDICAL 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355.

Insiders trading at AVITA Medical Inc

Over the last 5 years, insiders at AVITA Medical Inc have traded over $2,850,472 worth of AVITA Medical Inc stock and bought 19,459 units worth $293,310 . The most active insiders traders include Michael S Perry, James Corbett, and David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of $135,636. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth $8,900.

What does AVITA Medical Inc do?

avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.

Complete history of Jeremy Cook stock trades at Armata Pharmaceuticals Inc and AVITA Medical Inc

AVITA Medical Inc executives and stock owners

AVITA Medical Inc executives and other stock owners filed with the SEC include:

• Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D.,
  CEO, Pres & Exec. Director
• Erin Liberto,
  Chief Commercial Officer
• Andrew Quick,
  Chief Technology Officer
• Donna Shiroma,
  Gen. Counsel & Sec.
• Michael Bria Holder MBA,
  Chief Financial Officer
• Kathy M. McGee,
  Chief Operating Officer
• Debbie Garner,
  VP of Global Marketing
• David Fencil,
  VP of Global Operations
• Sean Ekins,
  Interim CFO
• Donna Shiroma,
  General Counsel
• David Mc Intyre,
  Chief Financial Officer
• Erin Liberto,
  Chief Commercial Officer
• David D O'toole,
  CFO
• Suzanne Crowe,
  
• James Corbett,
  CEO
• Kathy M. Mc Gee,
  Chief Operating Officer
• Michael Holder,
  Chief Financial Officer
• Lou Panaccio,
  
• Louis Drapeau,
  Director
• Jeremy Curnock Cook,
  
• Michael S Perry,
  Director
• Cary Guy Vance,
  
• Robert Mc Namara,
  
• Jan Stern Reed,